MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 79 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $132,000 | +33.3% | 51,819 | +6.5% | 0.00% | 0.0% |
| Q1 2020 | $99,000 | +41.4% | 48,649 | +51.1% | 0.00% | – |
| Q4 2019 | $70,000 | +42.9% | 32,207 | +1.6% | 0.00% | – |
| Q3 2019 | $49,000 | -62.9% | 31,686 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $132,000 | +4.8% | 31,907 | +6.0% | 0.00% | – |
| Q1 2019 | $126,000 | +82.6% | 30,094 | +25.6% | 0.00% | – |
| Q4 2018 | $69,000 | -71.5% | 23,969 | -0.8% | 0.00% | -100.0% |
| Q3 2018 | $242,000 | +44.0% | 24,152 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $168,000 | – | 23,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
| Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
| Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
| Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
| ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
| Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
| Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
| Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
| Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |